comprehensive -WSS

comprehensive

author：leisure time 2025-09-30 08:49:41 - browse：525

Illustration of a doctor and patient. The shadow behind the doctor displays 0s and 1s for artificial intelligence. –– health tech coverage from STAT — Molly Ferguson for STAT

The world’s largest technology companies are racing to build generative AI into every corner of health and medicine.

Microsoft has formed an alliance with the electronic health records vendor Epic to wire the technology into dozens of health software products. Google is infusing it into tools used by hospitals to collect and organize data on millions of patients. Not to be outdone, Amazon has unveiled a service to help build clinical note scribes, and is separately working to embed generative AI in drug research and development.

All of this has unfolded faster than federal regulators could blink — or answer questions about how the technology should be tested and evaluated, whether it will help or hurt patients, and how it will impact privacy and the use of personal data.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： People with substance use disorder deserve online privacy

WSS

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Information blocking fines are now fair game in health care

Why the quest to eradicate polio has stumbled

Gene editing the human germline: What are the risks?

Akili changes sales model for its ADHD video game treatment

What happened to the House vote on health price transparency?

focus

comprehensive

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Positive childhood experiences can help future health

Hollywood unions extend contract negotiations for actors

Health AI adoption puts security, privacy startups on investors' radar

Cancer drug shortages should be causing more outrage

Colonoscopy prep: Liquid

Medicare details structure of new drug price negotiation program

Plastic surgeons increase patient psychiatric screenings

Drug repurposing or repositioning? The language matters

Information blocking fines are now fair game in health care

explore

Eli Lilly CEO gives to Mike Pence presidential super PAC

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

AstraZeneca to buy developer of next

Asbestos, a deadly carcinogen, banned by EPA

U.K. researchers warn about biases in medical devices, algorithms

Leading voice in opioid treatment defends methadone clinic system

focus

explore

leisure time

focus